COMMUNIQUÉS West-GlobeNewswire

RxSight, Inc. Reports First Quarter 2025 Financial Results
07/05/2025
ALISO VIEJO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance
07/05/2025
ROCKVILLE, Md., May 07, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
OraSure Announces First Quarter 2025 Financial Results
07/05/2025
BETHLEHEM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for [...]
OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
07/05/2025
First Quarter 2025 Revenue Increased 17% Year-over-Year WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on [...]
Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update
07/05/2025
— Second quarter fiscal 2025 revenue increased 4.4% to $124.3 million — Year-to-date fiscal 2025 revenue declined 4.1% to $244.2 million — Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., May 07, [...]
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
07/05/2025
- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and [...]
Exagen Inc. Announces Proposed Public Offering of Common Stock
07/05/2025
CARLSBAD, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it has commenced an underwritten public offering of shares of its [...]
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
07/05/2025
Interim Data from Low Dose Cohort in MyPEAK TM -1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History [...]
InnovAge Earns Recertification as a Great Place to Work
07/05/2025
Employee feedback highlights pride in and commitment to serving the community DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- InnovAge, a leading provider of Program of All-Inclusive Care for the Elderly (PACE) services, is [...]
electroCore Announces First Quarter 2025 Financial Results
07/05/2025
First quarter 2025 net sales of $6.7 million, an increase of 23% over first quarter 2024 Closed the acquisition of NeuroMetrix, Inc. (“NeuroMetrix”); first quarter 2025 unaudited Quell net sales of approximately $170, [...]
Emergent BioSolutions Reports First Quarter 2025 Financial Results
07/05/2025
First Quarter 2025 Total Revenues of $222.2 million, decrease of 26% versus prior year First Quarter 2025 Net Income of $68.0 million, increase of 656% versus prior year First Quarter 2025 Gross Margin % of 50% and [...]
Anika to Participate in the Sidoti Virtual Investor Conference
07/05/2025
BEDFORD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention [...]
Design Therapeutics Highlights Momentum Across Lead GeneTAC® Programs and Reports First Quarter 2025 Financial Results
07/05/2025
Phase 1 Single Ascending Dose Trial of DT-216P2 for Friedreich Ataxia (FA) Program Ongoing Reported Favorable Phase 1 Data for DT-168 for Fuchs Endothelial Corneal Dystrophy (FECD) Program Well-Capitalized with Cash and [...]
Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports First Quarter 2025 Financial Results
07/05/2025
REDWOOD CITY, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided an [...]
Syndax Announces Publication of Pivotal Revumenib Data in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia in the Journal Blood
07/05/2025
– Primary endpoint met in R/R mNPM1 AML patients in pivotal Phase 2 portion of the AUGMENT-101 trial – – Robust remission rates in heavily pre-treated R/R mNPM1 AML population with nearly 50% overall response rate – – [...]
IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
07/05/2025
Phase 1 clinical data of INB-100 continues to demonstrate long-term durable remissions, with 100% of treated Acute Myeloid Leukemia (AML) patients remaining relapse-free with median follow-up of 20.1 months as of [...]
Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference
07/05/2025
NEWTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers [...]
Best Probiotic For Women: Top Strains for Gut Health, Vaginal health & Constipation - Women Over 40,50,60 - Bioma
07/05/2025
Birštonas, May 07, 2025 (GLOBE NEWSWIRE) -- In this health-conscious era, choosing a good probiotic for women is no longer a supplement option—it's a lifestyle choice for women's health, digestion, and well-being; with [...]
The Best Place to Buy SARMs Online and OTC: Top SARM Brand & Company for Muscle Growth & Fat Loss - Safe Legal SARMS for Sale - CrazyBulk
07/05/2025
New York City, May 07, 2025 (GLOBE NEWSWIRE) -- The best place to buy SARMs is presented by CrazyBulk SARMs are the hottest trend in bodybuilding right now. Bodybuilders, weightlifters, and athletes everywhere are [...]

Pages